Precision oncology using a clinician ‐directed, tailored approach to molecular profiling

ConclusionA clinician‐directed, tailored approach to the use of MP is feasible, resulting in 11% of patients enrolled onto molecularly matched trials.

Source: Asia-Pacific Journal of Clinical Oncology - October 30, 2017 Category: Cancer & Oncology Authors: Michael Lam, Ben Tran, Sophie Beck, Jeanne Tie, Dishan Herath, James Whittle, Edmond M. Kwan, Stephen B. Fox, Andrew Fellowes, Sumitra Ananda, Lara Lipton, Peter Gibbs, Mark A. Rosenthal, Jayesh Desai Tags: ORIGINAL ARTICLE Source Type: research